{"id":168816,"date":"2024-03-27T02:42:28","date_gmt":"2024-03-27T06:42:28","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/veterinary-scene-down-under-australian-animal-biotechnology-company-wins-2024-pet-care-inno-vation-prize-and-dvm-360\/"},"modified":"2024-08-17T16:14:39","modified_gmt":"2024-08-17T20:14:39","slug":"veterinary-scene-down-under-australian-animal-biotechnology-company-wins-2024-pet-care-inno-vation-prize-and-dvm-360","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/veterinary-scene-down-under-australian-animal-biotechnology-company-wins-2024-pet-care-inno-vation-prize-and-dvm-360.php","title":{"rendered":"Veterinary scene down under: Australian animal biotechnology company wins 2024 Pet Care Inno-vation Prize, and &#8230; &#8211; DVM 360"},"content":{"rendered":"<p><p>Shining a light on the illegal wildlife trade                                <\/p>\n<p>            Cameron Murray, BSc, BVMS, working with wildlife in            Africa (Image Courtesy of Cameron Murray)          <\/p>\n<p>    Away from the 4 small animal veterinary practices he co-owns,    Cameron Murray, BSc, BVMS, has a strong interest in wildlife    conservation. Starting with his involvement with SAVE African    Rhino Foundation he is now also a director of the charity    organization Nature Needs More, which is focused on demand    reduction projects to diminish the illegal global wildlife    trade.  <\/p>\n<p>    Murrays passion for wildlife conservation has led him to    playing a vital role in raising awareness of wildlife    trafficking and educating veterinarians about how they can help    make a difference. Nature Needs More works on tackling the key    systemic enablers of the illegal wildlife trade, including    consumer demand for wildlife products and the deficiencies in    the legal trade system under the Convention on International    Trade in Endangered Species of Wild Fauna and Flora (CITES).  <\/p>\n<p>    To give an understanding of the scale of the wildlife trade on    a global basis, legal trade is currently estimated to be worth    as much as USD$260-320 billion annually and if you include    illegal trade this may be as high as USD$500 billion. The legal    trade is monitored, regulated and managed, however that the    legal and illegal trade are currently functionally inseparable,    and until steps are taken to modernize the management of legal    trade, the issue of illegal trade will remain an unwinnable    battle, Murray explained to dvm360. Through Nature    Needs More, were advocating for a program of modernization of    CITES. This is because the landmark Intergovernmental    Science-Policy Platform on Biodiversity and Ecosystem Services    (IPBES) Global Assessment Report on Biodiversity and Ecosystem    Services report of 2019, suggested that 1 million species in    the world face extinction, and that direct exploitation through    trade was the biggest single threat to marine species and the    second largest behind habitat loss for terrestrial and fresh    water species.1  <\/p>\n<p>    Analysis of CITES wildlife trade records and published    literature has revealed massive numbers of animals are traded    live every year, with many presumably destined for the exotic    pet market. These records highlight the staggering numbers of    species caught up in the global wildlife trade, with over 500    species of birdapproximately half of which are parrots, almost    500 species of reptilemostly turtles, lizards and snakes, and    over 100 species of mammalmostly carnivores and primates,    said Murray. For Australia this has particular relevance for    our reptiles, which can be relatively easily smuggled. Sadly,    smuggling Australian native species is considered a low-risk    crime and there is significant financial motivation for    criminals to illegally export Australian wildlife for the    overseas exotic pet trade.  <\/p>\n<p>            fieldofvision\/stock.adobe.com          <\/p>\n<p>    A 2021 report compiled Australian seizure data and    international online trade data pertaining to shingleback    lizards, found that all 4 subspecies were involved in illegal    trade.2 This is important as 2    of these shingleback subspecies come from very limited ranges    and populations. As such, a trade of this nature poses a real    threat to species survival and biodiversity loss. All of us    should be concerned with regard to the issues of biodiversity    loss but in addition, the trade in wildlife also raises issues    around animal welfare, zoonotic disease spread, biosecurity    issues and more, Murray said.  <\/p>\n<p>    Veterinarians can play an important role by having a stronger    voice for change in the trade of wildlife, and as veterinarians    we are well placed to play a stronger lead in the area. We    should also be aware of the fact that there is active poaching    of native species and be vigilant to this possibility. We also    have an opportunity to see that penalties associated with    wildlife crime are more of a deterrent and finally, I would    encourage everyone to look behind the management systems of    wildlife trade and consider joining me in advocating for a    modernization of CITES, Murray added.  <\/p>\n<p>    After working as a veterinarian for almost a decade, Peter Lau,    BSc (Hons), BVMS, MBBS, FRACP, PhD, changed his focus and    graduated in human medicine in 2007 before becoming a    specialist medical oncologist. Currently based at Sir Charles    Gairdner Hospital and Harry Perkins Institute of Medical    Research in Perth, Lau and his colleagues Jonas Nilsson PhD,    and Zlatibor Velickovic, PhD, are now at the forefront of    cancer research in Australia with cellular immunotherapy for    human melanoma patients.  <\/p>\n<p>    Cell therapy using Tumor Infiltrating Lymphocytes (TILs)    involves surgically removing a patients melanoma deposit,    extracting out the T cells or lymphocytes which act against the    cancer. We then grow those cells in a specialized laboratory    expanding them to extremely high numbers in the order of    billions. Patients are admitted into hospital, receive    chemotherapy and then are injected with the TIL treatment which    destroys the tumor. The technology for cellular immunotherapy    was developed in Europe and the US but is not currently    available in Australia. Our recent grant funding will go    towards manufacturing this treatment for the first time in    Australia, Lau explained exclusively to dvm360.  <\/p>\n<p>    For decades metastatic melanoma has been a terrible cancer to    treat but with immunotherapy such as pembrolizumab we can now    literally save lives. These conventional immunotherapies dont    work in all patients hence the need for new treatments like    cell therapy. We do have a way to go in terms of curing    everyone from the disease but cell therapy research like this    can help close that gap. Its very satisfying to be at the    forefront of treatment and cancer research.  <\/p>\n<p>    Although Lau no longer works as a clinical veterinarian, he    credits his early career in the veterinary profession with    setting him up for success in the adjacent field of human    medicine. My interest in immunology started a number of years    ago listening to a talk from professor [Peter Doherty, PhD] at    an Australian Veterinary Association Conference many years ago.    Professor Doherty originally trained as a veterinarian and made    key discoveries in how the immune system recognizes cells    infected with viruses which led to a Nobel Prize. It was quiet    an inspirational talk and I ended up in medicine as a result.    Vet training did teach me a lot about persistence which is    really needed with research, Lau said. Canine melanoma is    also treated with similar drugs as we use in humans so its    quite nice to see the benefit of these immunotherapies for our    4-legged friends.  <\/p>\n<p>    VetChip, an Australian animal biotechnology company, won the    2024 Pet Care Innovation Prize, earning a cash prize and    support from Purina. VetChip was 1 of 5 pet care startups from    across the world that pitched their businesses to pet industry    influencers and investors at the recent Global Pet Expo in    Orlando, Florida.  <\/p>\n<p>    The biotechnology company is dedicated to improving animal    health and welfare through pioneering technology that monitors,    analyses, and detects pet health issues. VetChip cofounder and    veterinarian Garnett Hall, BVSc (Hons), travelled to the US for    the event.  <\/p>\n<p>            Garnett Hall, BVSc (Hons),VetChip co-founder (Image            courtesy of VetChip)          <\/p>\n<p>    \"The VetChip team and I are extremely grateful for the support    we have received from Purina through the Pet Care Innovation    Prize. Developing technology like ours is incredibly difficult,    and partnerships with leading animal health and technology    companies are essential for us, said Hall exclusively to    dvm360.  <\/p>\n<p>    2024 is off to a great start, and the remainder of this year    will see us commence pre-commercial trials in several of our    key markets. I am looking forward to using our technology to    improve the health, welfare and performance of military dogs    and and performance horses before the end of the yearmore to    announce soon.  <\/p>\n<p>    VetChip has developed an innovative implantable smart microchip    for animals that can monitor the animals temperature, heart    rate, respiratory rate and tissue oxygenation. VetChip has many    applications, including in companion animal practice, for    primary producers enabling better herd health management, and    for in equestrian sports and horse-racing.  <\/p>\n<p>    References  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the article here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.dvm360.com\/view\/veterinary-scene-down-under-australian-animal-biotechnology-company-wins-2024-pet-care-inno-vation-prize-and-more-news\" title=\"Veterinary scene down under: Australian animal biotechnology company wins 2024 Pet Care Inno-vation Prize, and ... - DVM 360\" rel=\"noopener\">Veterinary scene down under: Australian animal biotechnology company wins 2024 Pet Care Inno-vation Prize, and ... - DVM 360<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Shining a light on the illegal wildlife trade Cameron Murray, BSc, BVMS, working with wildlife in Africa (Image Courtesy of Cameron Murray) Away from the 4 small animal veterinary practices he co-owns, Cameron Murray, BSc, BVMS, has a strong interest in wildlife conservation. Starting with his involvement with SAVE African Rhino Foundation he is now also a director of the charity organization Nature Needs More, which is focused on demand reduction projects to diminish the illegal global wildlife trade.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/veterinary-scene-down-under-australian-animal-biotechnology-company-wins-2024-pet-care-inno-vation-prize-and-dvm-360.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-168816","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168816"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168816"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168816\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}